Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 14:02 | 18 Jun | 109.10 |
-1.60 (-1.45%) |
OPEN
112.25 |
HIGH
112.50 |
LOW
107.60 |
| NSE 13:59 | 18 Jun | 109.20 |
-1.50 (-1.36%) |
OPEN
111.55 |
HIGH
112.60 |
LOW
107.55 |
| OPEN | 112.25 |
| PREVIOUS CLOSE | 110.70 |
| VOLUME | 66867 |
| 52-Week high | 224.00 |
| 52-Week low | 91.50 |
| P/E | 16.71 |
| Mkt Cap.(Rs cr) | 1,128 |
| Buy Price | 108.95 |
| Buy Qty | 1.00 |
| Sell Price | 109.10 |
| Sell Qty | 1.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Half Yearly Result
Particulars ( cr) |
Mar '21 | Sep '20 | Mar '20 | Sep '19 | Mar '19 |
| Net Sales/Income From Operations | 232.67 | 232.84 | 222.78 | 219.17 | 201.78 |
| Other Income | 7.55 | 10.13 | 22.92 | 14.08 | -1.33 |
| Total Income | 240.22 | 242.97 | 245.70 | 233.25 | 200.44 |
| Total Expenditure | 186.19 | 187.86 | 180.88 | 160.91 | 163.20 |
| Operating Profit | 54.03 | 55.11 | 64.82 | 72.34 | 37.24 |
| Interest | 2.64 | 1.55 | 5.25 | 1.37 | 1.32 |
| Gross Profit | 51.39 | 53.56 | 59.57 | 70.97 | 35.92 |
| Depreciation | 6.88 | 6.88 | 4.47 | 4.36 | 2.79 |
| PBT | 44.52 | 46.67 | 55.10 | 66.62 | 33.14 |
| Tax | 11.76 | 10.76 | 16.30 | 15.61 | 17.50 |
| Net Profit/(Loss) | 31.62 | 35.88 | 39.98 | 52.36 | 16.34 |
| Minority Interest After NP | - | - | - | - | - |
| Net Profit after Minority Interest | - | - | - | - | - |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit After Exceptional Items | 31.62 | 35.88 | 39.98 | 52.36 | 16.34 |
| Equity Share Capital | 10.31 | 10.31 | 10.31 | 10.31 | 10.31 |
| Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS | |||||
| Basic EPS | 3.07 | 3.48 | 3.88 | 5.08 | 1.58 |
| Public Share Holding | |||||
| No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Promoters and Promoter Group Shareholding | |||||
| a) Pledged/Encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| b) Non-encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. | ||||
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
